Orbimed Advisors - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$29,816,000
-47.5%
2,878,000
-6.5%
0.55%
-19.4%
Q3 2018$56,843,000
-3.5%
3,079,2500.0%0.68%
-2.6%
Q2 2018$58,875,000
+23.9%
3,079,2500.0%0.70%
+19.2%
Q1 2018$47,513,000
-35.6%
3,079,250
-37.5%
0.59%
-36.9%
Q4 2017$73,829,000
-18.7%
4,925,200
-14.5%
0.93%
+7.6%
Q3 2017$90,823,000
-16.5%
5,759,2000.0%0.87%
-23.9%
Q2 2017$108,734,000
-12.0%
5,759,200
-20.5%
1.14%
-18.6%
Q1 2017$123,537,000
+11.6%
7,241,3000.0%1.40%
-0.8%
Q4 2016$110,719,000
-29.9%
7,241,300
-27.2%
1.41%
-21.6%
Q3 2016$157,990,000
+21.5%
9,949,0000.0%1.80%
+32.6%
Q2 2016$130,083,000
+2.9%
9,949,000
-13.9%
1.36%
+2.0%
Q1 2016$126,361,000
-2.9%
11,550,400
+2.9%
1.33%
+12.9%
Q4 2015$130,114,000
+11.2%
11,226,4000.0%1.18%
-0.3%
Q3 2015$116,979,000
-21.8%
11,226,400
-9.5%
1.18%
+7.6%
Q2 2015$149,574,000
-22.2%
12,402,500
+3.3%
1.10%
-33.1%
Q1 2015$192,194,000
+4.4%
12,012,1000.0%1.64%
-6.7%
Q4 2014$184,025,000
+18.3%
12,012,1000.0%1.76%
+8.2%
Q3 2014$155,617,000
+9.9%
12,012,100
+30.1%
1.62%
-2.3%
Q2 2014$141,586,000
+731.5%
9,235,900
+568.3%
1.66%
+695.7%
Q1 2014$17,027,0001,382,1000.21%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders